ACA
EHC icon

Atlas Capital Advisors’s Encompass Health EHC Stock Holding History

Atlas Capital Advisors’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.2K Sell
643
-126
-16% -$12.9K 0.01% 612
2025
Q4 		$81.6K Buy
+769
New +$89.1K 0.01% 566
2025
Q2 		$89.9K Sell
733
-476
-39% -$54.4K 0.01% 548
2025
Q1 		$122K Buy
1,209
+36
+3% +$3.52K 0.02% 509
2024
Q4 		$108K Sell
1,173
-51
-4% -$5.01K 0.01% 506
2024
Q3 		$118K Buy
1,224
+905
+284% +$81.3K 0.02% 468
2024
Q2 		$27.4K Sell
319
-79
-20% -$6.63K ﹤0.01% 658
2024
Q1 		$32.9K Hold
398
– – 0.01% 620
2023
Q4 		$26.6K Sell
398
-215
-35% -$13.9K ﹤0.01% 662
2023
Q3 		$41.2K Buy
613
+484
+375% +$33.3K 0.01% 563
2023
Q2 		$8.73K Sell
129
-203
-61% -$12.7K ﹤0.01% 748
2023
Q1 		$18K Sell
332
-3,907
-92% -$227K ﹤0.01% 699
2022
Q4 		$254K Buy
+4,239
New +$231K 0.04% 298

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Atlas Capital Advisors's EHC Position: Q1 2026 in Review

Atlas Capital Advisors reduced its Encompass Health (EHC) stake by 16% in Q1 2026, selling an estimated $12.9K and leaving 643 shares worth $62.2K. The position accounts for 0.01% of the portfolio, ranked #612.

Atlas Capital Advisors first reported a position in EHC in Q4 2022 and has held it in 13 quarters since. The position peaked at $254K in Q4 2022. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Atlas Capital Advisors held 643 shares of Encompass Health worth $62.2K as of Q1 2026.
  • Atlas Capital Advisors sold 126 Encompass Health shares in Q1 2026, an estimated $12.9K.
  • Encompass Health made up 0.01% of Atlas Capital Advisors's portfolio in Q1 2026, its #612 holding.
  • Atlas Capital Advisors first reported a position in Encompass Health in Q4 2022 and has held it in 13 quarters since.
  • Atlas Capital Advisors's Encompass Health position peaked at $254K in Q4 2022.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Atlas Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.